Specialty Pharmacy
Advertisement
What you need to know about the latest draft guidance for manufactures regarding medication guides and the current scene of classwide REMs.
Advertisement
Opposition to the Express Scripts-Medco merger stems from concerns over reduced access, increased prices, and diminished patient care.
Pharmacy Times publishes the third edition of this new journal with a special focus on oncology trends for the growing specialty pharmacy market.
What pharmacists need to know now about this standardization and how it affects the industry.
What each stakeholder needs to know about REMS in today's fast-paced climate.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Balancing Survival and Quality of Life in Pancreatic Cancer: Expert Perspectives From an Immuneering Panel
5